February 1, 2022
BHI’s next EIR Feedback Day is February 16th
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in…
February 1, 2022
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence…
February 1, 2022
BioHealth Innovation Announces Updates to its Board of Directors
Board of Directors Elects New Chair, Vice-Chair, and Two New Members ROCKVILLE, MARYLAND, January 31,…
January 31, 2022
Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH
POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and…
January 31, 2022
5 Cities Emerging As Future Hubs For Life Sciences Development
The current boom in life sciences development mirrors the tech industry, especially geographically; there is…
January 31, 2022
Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine
The Novavax vaccine would be the first protein-based alternative available in Israel GAITHERSBURG, Md., Jan.…
January 31, 2022
Maryland life science & digital health companies drive record VC investment. | Maryland Business News
In 2021, venture capitalists invested $2.27 billion in Maryland companies, according to the initial figures…
January 31, 2022
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma :: Immunocore PLC
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, Wednesday, January 26, 2022) Immunocore Holdings…